Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients

Chao Cen1, Qiuying Du2, Bin Luo3

  • 1Department of Gastroenterology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, China.

Open Life Sciences
|April 8, 2024
PubMed

Insights

Helicobacter pylori infection disrupts the gastric flora in chronic gastritis patients, leading to significant changes in microbial composition and function. This study provides a basis for preventing H. pylori infection and its harmful effects.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Genomics

Background:

  • Chronic gastritis (CG) is often associated with Helicobacter pylori (H. pylori) infection.
  • The impact of H. pylori on the gastric microbial community in CG patients requires further elucidation.

Purpose of the Study:

  • To investigate the alterations in gastric flora composition and function in CG patients with H. pylori infection.
  • To explore the pathogenic mechanisms of H. pylori-induced gastric dysbiosis.

Main Methods:

  • 16S ribosomal RNA (16S rRNA) gene sequencing of gastric mucosal samples from H. pylori-positive (HP_Pos) and H. pylori-negative (HP_Neg) CG patients.
  • Operational taxonomic unit (OTU) analysis and microbial community profiling.
  • Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for functional prediction.
  • Animal experiments to validate functional gene enrichment and pathogenic effects.

Main Results:

  • Significant differences in gastric flora composition were observed between HP_Pos and HP_Neg groups.
  • Key phyla included Bacteroidetes, Proteobacteria, Firmicutes, Actinobacteria, and Epsilonbacteraeota; key genera included Helicobacter, Lachnospiraceae_NK4A136_group, Bacteroides, Klebsiella, and Pseudomonas.
  • Distinct variations in KEGG metabolic pathways were identified between the groups.
  • H. pylori infection in mice led to inflammation, increased gastric acid secretion, elevated gastric activity, and higher malondialdehyde levels.

Conclusions:

  • H. pylori infection induces gastric dysbiosis in CG patients.
  • Altered gastric flora and function contribute to H. pylori-associated pathogenesis.
  • Findings support the importance of H. pylori eradication for preventing gastric disease complications.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
385
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
322
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
166
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
578
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
399
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
234